Awarded without open competition
Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.
Key facts
- Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
- Value
- £1,401,300 across 4 lots
- Procedure
- Award procedure without prior publication of a call for competition
- Sector
- Medical equipment & pharmaceuticals · Laboratory reagents (CPV 33696500)
- Region
- Scotland
- Official notice
- 000339-2025 on Find a Tender
- Timeline
-
- Contract date18 Dec 2024
- Published7 Jan 2025Published 20 days after the contract date
Description
SNBTS are under contract with RTx to manufacture the RTX001 product throughout 2025. RTx have transferred their manufacturing procedure to SNBTS and SNBTS are required to use the reagents/consumables specified by RTx within that process. BioTechne were the chosen supplier of cytokines for use within the trial by RTX, therefore SNBTS are required to procure these reagents from this supplier.
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| TCAT - RTX Project: Cytokines | Bio-Techne Ltd | £509k |
| TCAT - RTX Project: P3 buffer and nucleofector consumables | Lonza | £206k |
| TCAT - RTX Project: Prodigy cell processor | Miltenyi Biotec Ltd | £631k |
| TCAT - RTX Project: Rotea kits | Life Technologies Limited | £55,300 |
About the suppliers
Bio-Techne Ltd: every public contract they have won, plus their Companies House record (company 02490104).
Lonza: every public contract they have won.
Miltenyi Biotec Ltd: every public contract they have won.
Life Technologies Limited: every public contract they have won, plus their Companies House record (company SC083107).